Company intelligence / Profile preview
VT BIO CO., LTD.
- Ownership
- Private
- Development stage
- Other
Overview
VT BIO CO., LTD. develops therapeutics based on natural products and immune-regulatory cellular therapies. The company has completed pre-clinical studies showing efficacy of regulatory T cells in Alzheimer’s models and has advanced to clinical trials for dementia and depression treatments. Its COPD program reached Phase III before being licensed out to Hanlim Pharmaceutical. The company also commercializes functional hair loss shampoos/treatments using novel materials with proven efficacy.
- Therapeutic areas
- PulmonologyPsychiatryDermatologyNeurology
- Modalities
- Natural products-derived small molecules and compoundsImmune-regulatory cell therapy (regulatory T cells)Functional cosmetics (hair loss shampoo/treatments)
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on VT BIO CO., LTD..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VT BIO CO., LTD..